EcoDrugPlus

Potassium Voltage-Gated Channel, Subfamily H (Eag-Related), Member 2a

Ensembl ID : ENSPKIG00000007378
Gene Symbol: KCNH2A
1 Cross references
156 Possible Orthologues:

Potassium-Transporting Atpase Subunit Beta-Like

Ensembl ID : ENSPKIG00000008098
Gene Symbol: LOC111845443
2 Cross references
184 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSPKIG00000007791
Gene Symbol: PSEN1
3 Cross references
200 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSPKIG00000024241
Gene Symbol: PSEN2
3 Cross references
205 Possible Orthologues:

Progesterone Receptor-Like

Ensembl ID : ENSPKIG00000014228
Gene Symbol: LOC111841420
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPKIG00000009026
Gene Symbol: PTGDR2
3 Cross references
144 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPKIG00000025294
Gene Symbol: PTGDR2
4 Cross references
135 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSPKIG00000008380
Gene Symbol: PTGER1
3 Cross references
167 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSPKIG00000013768
Gene Symbol: PTGER2A
1 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSPKIG00000021722
Gene Symbol: PTGER3
3 Cross references
195 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSPKIG00000020041
Gene Symbol: PTGER4
1 Cross references
131 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSPKIG00000018854
Gene Symbol: PTGER4A
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).